anthrax vaccines - Medical Dictionary

Home | anthrax vaccines - Medical Dictionary |


anthrax vaccines		Vaccines or candidate vaccines used to prevent anthrax.

Additional comments : Articles Interlaboratory Comparison of the Anthrax Lethal Toxin Neutralization Assay used to Assess Functional Antibodies in Multiple Species. Authors: Omland KS, Brys A, Lansky D, Clement K, Lynn F, Journal: Clin Vaccine Immunol Bacillus anthracis: Balancing innocent research with dual-use potential. Authors: Hudson MJ, Beyer W, Böhm R, Fasanella A, Garofolo G, Golinski R, Goossens PL, Hahn U, Hallis B, King A, Mock M, Montecucco C, Ozin A, Tonello F, Kaufmann SH Journal: Int J Med Microbiol Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization. Authors: Li H, Soroka SD, Taylor TH, Stamey KL, Stinson KW, Freeman AE, Abramson DR, Desai R, Cronin LX, Oxford JW, Caba J, Pleatman C, Pathak S, Schmidt DS, Semenova VA, Martin SK, Wilkins PP, Quinn CP Journal: J Immunol Methods Discovery and development of anthrax lethal factor metalloproteinase inhibitors. Authors: Turk BE Journal: Curr Pharm Biotechnol Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant. Authors: Park YS, Lee JH, Hung CF, Wu TC, Kim TW Journal: Infect Immun Anthrax in red deer (Cervus elaphus), Italy. Authors: Fasanella A, Palazzo L, Petrella A, Quaranta V, Romanelli B, Garofolo G Journal: Emerg Infect Dis Serum IgG antibody response to the protective antigen (PA) of Bacillus anthracis induced by anthrax vaccine adsorbed (AVA) among U.S. military personnel. Authors: Singer DE, Schneerson R, Bautista CT, Rubertone MV, Robbins JB, Taylor DN Journal: Vaccine Preattack vaccination against anthrax may be cost-effective in certain populations. Authors: Hopkins RJ, Waytes TA, Zink TK Journal: Arch Intern Med Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens. Authors: Sloat BR, Shaker DS, Le UM, Cui Z Journal: FEMS Immunol Med Microbiol Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates. Authors: Yan M, Roehrl MH, Basar E, Wang JY Journal: Vaccine Vaccines: countering anthrax: vaccines and immunoglobulins. Authors: Grabenstein JD Journal: Clin Infect Dis Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses. Authors: Zhang Y, Qiu J, Zhou Y, Farhangfar F, Hester J, Lin AY, Decker WK Journal: Vaccine A mathematical simulation of the inflammatory response to anthrax infection. Authors: Kumar R, Chow CC, Bartels JD, Clermont G, Vodovotz Y Journal: Shock [Assessment of immunity and allergy after vaccination with dry combined anthrax vaccine] Authors: Shevtsov AN, Darmov IV, Saîtseva GA, Borovskoî DV, Menovshchikov VA, Kunof VK, Gracheva TA Journal: Zh Mikrobiol Epidemiol Immunobiol Neutralizing activity of vaccine-induced antibodies to two Bacillus anthracis toxin components, lethal factor and edema factor. Authors: Taft SC, Weiss AA Journal: Clin Vaccine Immunol A novel immunogenic spore coat-associated protein in Bacillus anthracis: characterization via proteomics approaches and a vector-based vaccine system. Authors: Liu YT, Lin SB, Huang CP, Huang CM Journal: Protein Expr Purif Catalytically inactive anthrax toxin(s) are potential prophylactic agents. Authors: Gupta M, Alam S, Bhatnagar R Journal: Vaccine A study of the physiology of Bacillus anthracis Sterne during manufacture of the UK acellular anthrax vaccine. Authors: Charlton S, Herbert M, McGlashan J, King A, Jones P, West K, Roberts A, Silman N, Marks T, Hudson M, Hallis B Journal: J Appl Microbiol A viral nanoparticle with dual function as an anthrax antitoxin and vaccine. Authors: Manayani DJ, Thomas D, Dryden KA, Reddy V, Siladi ME, Marlett JM, Rainey GJ, Pique ME, Scobie HM, Yeager M, Young JA, Manchester M, Schneemann A Journal: PLoS Pathog Systemic but not mucosal immunity induced by AVA prevents inhalational anthrax. Authors: Klinman DM, Currie D, Lee G, Grippe V, Merkel T Journal: Microbes Infect Anthrax vaccination in a military population before the war in Iraq: side effects and informed choice. Authors: Murphy D, Hull L, Horn O, Jones M, Marteau T, Hotopf M, Rona RJ, Wessely S Journal: Vaccine Anthrax vaccine and public health policy. Authors: Weiss MM, Weiss PD, Weiss JB Journal: Am J Public Health [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis] Authors: Mikshis NI, Kudriavtseva OM, Bolothikova MF, Shulepov DV, Novikova LV, Popov IuA, Shchukovskaia TN, Drozdov IG, Kutyrev VV Journal: Mol Gen Mikrobiol Virusol Safety, reactogenicity and immunogenicity of a recombinant protective antigen anthrax vaccine given to healthy adults. Authors: Campbell JD, Clement KH, Wasserman SS, Donegan S, Chrisley L, Kotloff KL Journal: Hum Vaccin Response to letter to the editor "Zink TK. Vaccine 2007;25(15):2766-7". Authors: Gorse GJ, Keitel W, Keyserling H, Taylor DN, Lock M, Alves K, Kenner J, Deans L, Gurwith M Journal: Vaccine Recombinant exosporium protein BclA of Bacillus anthracis is effective as a booster for mice primed with suboptimal amounts of protective antigen. Authors: Brahmbhatt TN, Darnell SC, Carvalho HM, Sanz P, Kang TJ, Bull RL, Rasmussen SB, Cross AS, O'Brien AD Journal: Infect Immun Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracis. Authors: Cowan GJ, Atkins HS, Johnson LK, Titball RW, Mitchell TJ Journal: Vaccine Paratope diversity in the human antibody response to Bacillus anthracis protective antigen. Authors: Zhou J, Ullal A, Liberato J, Sun J, Keitel W, Reason DC Journal: Mol Immunol [Molecular study of Argentine strains of Bacillus anthracis] Authors: Cairó F, Pavan ME Journal: Rev Argent Microbiol Potential biological targets of Bacillus anthracis in anti-infective approaches against the threat of bioterrorism. Authors: Bouzianas DG Journal: Expert Rev Anti Infect Ther Bacillus anthracis: interactions with the host and establishment of inhalational anthrax. Authors: Passalacqua KD, Bergman NH Journal: Future Microbiol WITHDRAWN: Vaccines for preventing anthrax. Authors: Jefferson T, Demicheli V, Deeks J, Graves P, Pratt M, Rivetti D Journal: Cochrane Database Syst Rev In vitro screen of bioinformatically selected Bacillus anthracis vaccine candidates by coupled transcription, translation, and immunoprecipitation analysis. Authors: Gat O, Grosfeld H, Shafferman A Journal: Methods Mol Biol Project BioShield: what it is, why it is needed, and its accomplishments so far. Authors: Russell PK Journal: Clin Infect Dis Development of a competitive enzyme linked immunosorbent assay to identify epitope specific antibodies in recipients of the U.S. licensed anthrax vaccine. Authors: Gubbins MJ, Schmidt L, Tsang RS, Berry JD, Kabani A, Stewart DI Journal: J Immunoassay Immunochem Recent progress in biodefence countermeasure development. Authors: Mair M Journal: Biosecur Bioterror Immune response to two different dosing schedules of the anthrax vaccine precipitated (AVP) vaccine. Authors: Hepburn MJ, Hugh Dyson E, Simpson AJ, Brenneman KE, Bailey N, Wilkinson L, Hornby R, Mateczun AJ, Bell MG, Baillie LW Journal: Vaccine Detection of anti-protective antigen salivary IgG antibodies in recipients of the US licensed anthrax vaccine. Authors: Bienek DR, Chang CK, Cohen ME Journal: Vaccine Evaluation of immune response to orally administered Sterne strain 34F2 anthrax vaccine. Authors: Shakya KP, Hugh-Jones ME, Elzer PH Journal: Vaccine New insights into the pathogenesis and treatment of anthrax toxin-induced shock. Authors: Li Y, Sherer K, Cui X, Eichacker PQ Journal: Expert Opin Biol Ther [Properties of live antibiotics-resistant anthrax vaccine STI-PR after long-term storage] Authors: Aksenova LIu, Buravtseva NP, Kogotkova OI, Eremenko EI, Tsygankova OI Journal: Zh Mikrobiol Epidemiol Immunobiol Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge. Authors: Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, Peterson JW, Baker JR Journal: Infect Immun Evaluation of combinatorial vaccines against anthrax and plague in a murine model. Authors: DuBois AB, Freytag LC, Clements JD Journal: Vaccine Transcriptional stimulation of anthrax toxin receptors by anthrax edema toxin and Bacillus anthracis Sterne spore. Authors: Xu Q, Hesek ED, Zeng M Journal: Microb Pathog Public health response to an anthrax attack: an evaluation of vaccination policy options. Authors: Baccam P, Boechler M Journal: Biosecur Bioterror Assessment of anthrax vaccination data in the Defense Medical Surveillance System, 1998-2004. Authors: Payne DC, Rose CE, Aranas A, Zhang Y, Tolentino H, Weston E, McNeil MM, Ruscio B Journal: Pharmacoepidemiol Drug Saf Responding to a small-scale bioterrorist anthrax attack: cost-effectiveness analysis comparing preattack vaccination with postattack antibiotic treatment and vaccination. Authors: Schmitt B, Dobrez D, Parada JP, Kyriacou DN, Golub RM, Sharma R, Bennett C Journal: Arch Intern Med Anthrax vaccination in the Millennium Cohort: validation and measures of health. Authors: Smith B, Leard CA, Smith TC, Reed RJ, Ryan MA, Journal: Am J Prev Med Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge. Authors: Huang J, Mikszta JA, Ferriter MS, Jiang G, Harvey NG, Dyas B, Roy CJ, Ulrich RG, Sullivan VJ Journal: Hum Vaccin Adverse reactions to anthrax vaccine (eg, optic neuritis) may be more complex or delayed than reported initially by Payne et al (2006). Authors: Schumm WR Journal: Arch Neurol A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor. Authors: Walsh JJ, Pesik N, Quinn CP, Urdaneta V, Dykewicz CA, Boyer AE, Guarner J, Wilkins P, Norville KJ, Barr JR, Zaki SR, Patel JB, Reagan SP, Pirkle JL, Treadwell TA, Messonnier NR, Rotz LD, Meyer RF, Stephens DS Journal: Clin Infect Dis Cutting Edge: IFN-gamma-producing CD4 T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis. Authors: Glomski IJ, Corre JP, Mock M, Goossens PL Journal: J Immunol Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine. Authors: Zeng M, Xu Q, Pichichero ME Journal: Vaccine Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine. Authors: Grunow R, Porsch-Ozcürümez M, Splettstoesser W, Buckendahl A, Hahn U, Beyer W, Böhm R, Huber M, vd Esche U, Bessler W, Frangoulidis D, Finke EJ Journal: Vaccine Antigen-specific CD4+ T cells recognize epitopes of protective antigen following vaccination with an anthrax vaccine. Authors: Laughlin EM, Miller JD, James E, Fillos D, Ibegbu CC, Mittler RS, Akondy R, Kwok W, Ahmed R, Nepom G Journal: Infect Immun Immunogenicity of a subunit vaccine against Bacillus anthracis. Authors: Chichester JA, Musiychuk K, de la Rosa P, Horsey A, Stevenson N, Ugulava N, Rabindran S, Palmer GA, Mett V, Yusibov V Journal: Vaccine Massive outbreak of anthrax in wildlife in the Malilangwe Wildlife Reserve, Zimbabwe. Authors: Clegg SB, Turnbull PC, Foggin CM, Lindeque PM Journal: Vet Rec A comparative assessment of immunization records in the Defense Medical Surveillance System and the Vaccine Adverse Event Reporting System. Authors: McNeil MM, Ma G, Aranas A, Payne DC, Rose CE Journal: Vaccine Short-term reactogenicity and gender effect of anthrax vaccine: analysis of a 1967-1972 study and review of the 1955-2005 medical literature. Authors: McNeil MM, Chiang IS, Wheeling JT, Zhang Y Journal: Pharmacoepidemiol Drug Saf Effect of aluminum hydroxide adjuvant and formaldehyde in the formulation of rPA anthrax vaccine. Authors: Little SF, Ivins BE, Webster WM, Norris SL, Andrews GP Journal: Vaccine Results of a safety and immunogenicity study of an early-stage investigational rPA102 vaccine as compared to the FDA licensed anthrax vaccine (anthrax vaccine adsorbed (AVA. BioThrax)). Authors: Hannesschlager JR Journal: Vaccine Analysis of anti-protective antigen IgG subclass distribution in recipients of anthrax vaccine adsorbed (AVA) and patients with cutaneous and inhalation anthrax. Authors: Semenova VA, Schmidt DS, Taylor TH, Li H, Steward-Clark E, Soroka SD, Ballard MM, Quinn CP Journal: Vaccine Gorse GJ, et al. "Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial" [Vaccine 24 (2006) 5950-5959]. Authors: Zink TK Journal: Vaccine Molecular study of genes involved in virulence regulatory pathways in Bacillus anthracis vaccine strain "Carbosap". Authors: La Rosa G, Muscillo M, Sali M, De Carolis E, Marianelli C, Ciuchini F, Fasanella A, Adone R Journal: New Microbiol Anticipating demand for emergency health services due to medication-related adverse events after rapid mass prophylaxis campaigns. Authors: Hupert N, Wattson D, Cuomo J, Benson S Journal: Acad Emerg Med The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics. Authors: Doolan DL, Freilich DA, Brice GT, Burgess TH, Berzins MP, Bull RL, Graber NL, Dabbs JL, Shatney LL, Blazes DL, Bebris LM, Malone MF, Eisold JF, Mateczun AJ, Martin GJ Journal: J Infect Dis Learning from the 2001 anthrax attacks: immunological characteristics. Authors: Hadler JL Journal: J Infect Dis Chloroplast-derived anthrax and other vaccine antigens: their immunogenic and immunoprotective properties. Authors: Kamarajugadda S, Daniell H Journal: Expert Rev Vaccines Data vs conclusions in the optic neuritis vaccination investigation. Authors: Nass M Journal: Arch Neurol Adenovirus-based prime-boost immunization for rapid vaccination against anthrax. Authors: McConnell MJ, Hanna PC, Imperiale MJ Journal: Mol Ther The impact of incomplete vaccination schedules on the magnitude and duration of protective antigen-specific IgG responses in recipients of the US licensed anthrax vaccine. Authors: Lininger LA, Cullum ME, Lyles MB, Bienek DR Journal: Vaccine Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis. Authors: Stokes MG, Titball RW, Neeson BN, Galen JE, Walker NJ, Stagg AJ, Jenner DC, Thwaite JE, Nataro JP, Baillie LW, Atkins HS Journal: Infect Immun CpG oligonucleotides improve the protective immune response induced by the licensed anthrax vaccine. Authors: Klinman DM, Xie H, Ivins BE Journal: Ann N Y Acad Sci Multicomponent anthrax toxin display and delivery using bacteriophage T4. Authors: Shivachandra SB, Li Q, Peachman KK, Matyas GR, Leppla SH, Alving CR, Rao M, Rao VB Journal: Vaccine Anthrax in South Africa: economics, experiment and the mass vaccination of animals, c. 1910-1945. Authors: Gilfoyle D Journal: Med Hist Cloning and expression in E. coli of a functional Fab fragment obtained from single human lymphocyte against anthrax toxin. Authors: Masri SA, Rast H, Hu WG, Nagata LP, Chau D, Jager S, Mah D Journal: Mol Immunol Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine. Authors: Mikszta JA, Dekker JP, Harvey NG, Dean CH, Brittingham JM, Huang J, Sullivan VJ, Dyas B, Roy CJ, Ulrich RG Journal: Infect Immun Generalized cutaneous reactions to the anthrax vaccine: preliminary results of anthrax vaccine-specific cell mediated immunity and cytokine profiles. Authors: Parker AL, England RW, Nguyen SA, Whisman BA, Hagan LL Journal: Hum Vaccin Military hospitalizations among deployed US service members following anthrax vaccination, 1998-2001. Authors: Wells TS, Sato PA, Smith TC, Wang LZ, Reed RJ, Ryan MA Journal: Hum Vaccin Investigation in a model system of the effects of combinations of anthrax and pertussis vaccines administered to service personnel in the 1991 Gulf War. Authors: Rijpkema SG, Adams T, Rigsby P, Xing DK, Corbel MJ Journal: Hum Vaccin Application of paramagnetic beads for purifying Bacillus anthracis protective antigen. Authors: Zarzecka A, Bartoszcze M Journal: J Vet Med B Infect Dis Vet Public Health Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen. Authors: Duc le H, Hong HA, Atkins HS, Flick-Smith HC, Durrani Z, Rijpkema S, Titball RW, Cutting SM Journal: Vaccine Recombinant protective antigen 102 (rPA102): profile of a second-generation anthrax vaccine. Authors: Keitel WA Journal: Expert Rev Vaccines Mass vaccination: solutions in the skin. Authors: Glenn GM, Kenney RT Journal: Curr Top Microbiol Immunol Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity. Authors: Vitale L, Blanset D, Lowy I, O'Neill T, Goldstein J, Little SF, Andrews GP, Dorough G, Taylor RK, Keler T Journal: Infect Immun Increased potency of BioThrax anthrax vaccine with the addition of the C-class CpG oligonucleotide adjuvant CPG 10109. Authors: Gu M, Hine PM, James Jackson W, Giri L, Nabors GS Journal: Vaccine Anthrax vaccines: Pasteur to the present. Authors: Scorpio A, Blank TE, Day WA, Chabot DJ Journal: Cell Mol Life Sci Factors influencing laboratory workers' decisions to accept or decline anthrax vaccine adsorbed (AVA): results of a decision-making study in CDC's anthrax vaccination program. Authors: Fowler GL, Baggs JM, Weintraub ES, Martin SW, McNeil MM, Gust DA Journal: Pharmacoepidemiol Drug Saf CpG 7909: PF 3512676, PF-3512676. Authors: Journal: Drugs R D Past, imminent and future human medical countermeasures for anthrax. Authors: Baillie LW Journal: J Appl Microbiol On the use of zero-inflated and hurdle models for modeling vaccine adverse event count data. Authors: Rose CE, Martin SW, Wannemuehler KA, Plikaytis BD Journal: J Biopharm Stat New-onset rheumatoid arthritis after anthrax vaccination. Authors: Vasudev M, Zacharisen MC Journal: Ann Allergy Asthma Immunol Diversity of Bacillus anthracis strains in Georgia and of vaccine strains from the former Soviet Union. Authors: Merabishvili M, Natidze M, Rigvava S, Brusetti L, Raddadi N, Borin S, Chanishvili N, Tediashvili M, Sharp R, Barbeschi M, Visca P, Daffonchio D Journal: Appl Environ Microbiol Surgical infection society guidelines for vaccination after traumatic injury. Authors: Howdieshell TR, Heffernan D, Dipiro JT, Journal: Surg Infect (Larchmt) Additional conjugation methods and immunogenicity of Bacillus anthracis poly-gamma-D-glutamic acid-protein conjugates. Authors: Kubler-Kielb J, Liu TY, Mocca C, Majadly F, Robbins JB, Schneerson R Journal: Infect Immun Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli. Authors: Sloat BR, Cui Z Journal: Vaccine Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice. Authors: Lee JS, Groebner JL, Hadjipanayis AG, Negley DL, Schmaljohn AL, Welkos SL, Smith LA, Smith JF Journal: Vaccine CpG oligonucleotides accelerate and boost the immune response elicited by AVA, the licensed anthrax vaccine. Authors: Klinman DM Journal: Expert Rev Vaccines Rabies virus glycoprotein as a carrier for anthrax protective antigen. Authors: Smith ME, Koser M, Xiao S, Siler C, McGettigan JP, Calkins C, Pomerantz RJ, Dietzschold B, Schnell MJ Journal: Virology Engineered chloroplasts as vaccine factories to combat bioterrorism. Authors: Streatfield SJ Journal: Trends Biotechnol

Back